Jaume Barallat

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 13

Top Topics

Circulating Tumor Cells

Ultra High Performance Liquid Chromatography

Top Venues

Mikrochimica acta

Clinical chemistry and laboratory medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Gloria Colom, Alejandro Hernandez-Albors, Jaume Barallat, Amparo Galan, Antoni Bayés-Genís, Juan-Pablo Salvador, María-Pilar Marco
A multiplexed immunochemical microarray for the determination of cardiovascular disease biomarkers. Mikrochimica acta 191 (1) (2023)
Jaume Barallat, Carolina Gómez, Ana Sancho-Cerro
AI, diabetes and getting lost in translation: a multilingual evaluation of Bing with ChatGPT focused in HbA 1c . Clinical chemistry and laboratory medicine (2023)
Jaume Barallat, Carolina Gómez-Gómez, Ana Sancho-Cerro
Let's Face It: Chatbots Are Here to Stay. The journal of applied laboratory medicine 8 (5) (2023)
Gloria Colom, Alejandro Hernandez-Albors, Jaume Barallat, Amparo Galan, Antoni Bayés-Genís, Juan-Pablo Salvador, María-Pilar Marco
A multiplexed immunochemical microarray for the determination of cardiovascular disease biomarkers. Mikrochimica acta 191 (1) (2023)
Gloria Colom, Alejandro Hernandez-Albors, Jaume Barallat, Amparo Galan, Antoni Bayés-Genís, Juan-Pablo Salvador, María-Pilar Marco
A multiplexed immunochemical microarray for the determination of cardiovascular disease biomarkers. Mikrochimica acta 191 (1) (2023)
Gloria Colom, Alejandro Hernandez-Albors, Jaume Barallat, Amparo Galan, Antoni Bayés-Genís, Juan-Pablo Salvador, María-Pilar Marco
A multiplexed immunochemical microarray for the determination of cardiovascular disease biomarkers. Mikrochimica acta 191 (1) (2023)
Gloria Colom, Alejandro Hernandez-Albors, Jaume Barallat, Amparo Galan, Antoni Bayés-Genís, Juan-Pablo Salvador, María-Pilar Marco
A multiplexed immunochemical microarray for the determination of cardiovascular disease biomarkers. Mikrochimica acta 191 (1) (2023)
Gloria Colom, Alejandro Hernandez-Albors, Jaume Barallat, Amparo Galan, Antoni Bayés-Genís, Juan-Pablo Salvador, María-Pilar Marco
A multiplexed immunochemical microarray for the determination of cardiovascular disease biomarkers. Mikrochimica acta 191 (1) (2023)
Gema Fernández-Rivas, Jaume Barallat, Bibiana Quirant-Sanchez, Victoria González, María Doladé, Eva Martinez-Caceres, Monica Piña, Joan Matllo, Ignacio Blanco, Pere Joan Cardona
Follow up of the Humoral Response in Healthcare Workers after the Administration of Two Dose of the Anti SARS-CoV-2 Vaccines-Effectiveness in Delta Variant Breakthrough Infections. Viruses 14 (7) (2022)
María José Mansilla, Íñigo González-Larreategui, Neus Figa-Martín, Jaume Barallat, Federico Fondelli, Ares Sellés-Rius, Bibiana Quirant-Sánchez, Aina Teniente-Serra, Eva M Martínez-Cáceres
Transfection of Vitamin D3-Induced Tolerogenic Dendritic Cells for the Silencing of Potential Tolerogenic Genes. Identification of CSF1R-CSF1 Signaling as a Glycolytic Regulator. International journal of molecular sciences 22 (14) (2021)
Teresa-Maria Tomasa-Irriguible, Lara Bielsa-Berrocal, María Luisa Bordejé Laguna, Cristina Tural-Llàcher, Jaume Barallat, Josep María Manresa, Jordi Segura-Bernal
Low Levels of Few Micronutrients May Impact COVID-19 Disease Progression: An Observational Study on the First Wave. Metabolites 11 (9) (2021)
Elena Revuelta-López, Jaume Barallat, Adriana Cserkóová, Carolina Gálvez-Montón, Allan S Jaffe, James L Januzzi, Antoni Bayes-Genis
Pre-analytical considerations in biomarker research: focus on cardiovascular disease. Clinical chemistry and laboratory medicine 59 (11) (2021)
Jaume Barallat, Gema Fernández-Rivas, Bibiana Quirant-Sanchez, Victoria González, Maria Doladé, Eva Martinez-Caceres, Mònica Piña Rodríguez, Joan Matllo, Oriol Estrada, Ignacio Blanco
Seroprevalence of SARS-CoV-2 IgG specific antibodies among healthcare workers in the Northern Metropolitan Area of Barcelona, Spain, after the first pandemic wave. PloS one 15 (12) (2020)